Calling All Investors: Let’s Talk About Direct Digital Holdings Inc. (DRCT) – A Friendly Reminder from Bronstein, Gewirtz & Grossman LLC!

Welcome to the Wild World of Stock Market Investigations! Investing can be a rollercoaster ride full of ups and downs, twists and turns, and unexpected surprises. One minute you’re feeling like a financial genius, and the next you’re scratching your head wondering what went wrong. Well, if you’re a shareholder of Direct Digital Holdings Inc….

Read More

Act Now: Faruqi & Faruqi LLP Investigates Claims for Investors of Customers Bancorp – Don’t Miss the Deadline!

Faruqi & Faruqi, LLP Securities Litigation Partner Encourages Investors to Discuss Their Options Losses in Customers Bancorp If you suffered losses exceeding $75,000 in Customers Bancorp between March 1, 2024 and August 8, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext….

Read More

Introducing the New Scientific Advisory Board at Lexaria: Enhancing Innovation and Expertise

North American drug delivery development experts added to help guide Lexaria’s strategic plans Introduction Lexaria Bioscience Corp., a global innovator in drug delivery platforms, has recently announced the creation of its new Scientific Advisory Board (SAB) to assist in guiding the company’s rapid drug delivery platform technology and strategic development plans within the pharmaceutical industry….

Read More

Get Ready to Revolutionize: Applied DNA’s Customer HKT Launches Phase I Clinical Trial for Speedy and Scalable CAR-T Cell Therapy Made with Linea DNA!

Regulatory Approval Showcases Clinical Advancement of Linea DNA™ for CAR-T Therapy STONY BROOK, NY / ACCESSWIRE / December 18, 2024 Exciting news in the world of medical advancements! Applied DNA Sciences, Inc. (NASDAQ:APDN), a leader in PCR-based DNA technologies, has recently announced a significant milestone in the field of CAR-T cell therapy. The State Institute…

Read More